Literature DB >> 21507927

Simultaneous use of other antimicrobials may have influenced clinical outcomes.

James A McKinnell, Samantha J Eells, Angel A Wang, Loren G Miller.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 21507927      PMCID: PMC3916747          DOI: 10.1093/cid/cir135

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  4 in total

1.  In vitro double and triple bactericidal activities of doripenem, polymyxin B, and rifampin against multidrug-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli.

Authors:  Carl Urban; Noriel Mariano; James J Rahal
Journal:  Antimicrob Agents Chemother       Date:  2010-04-05       Impact factor: 5.191

2.  How soon is now? The urgent need for randomized, controlled trials evaluating treatment of multidrug-resistant bacterial infection.

Authors:  David L Paterson; Benjamin A Rogers
Journal:  Clin Infect Dis       Date:  2010-10-25       Impact factor: 9.079

3.  Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case-control study.

Authors:  Diamantis P Kofteridis; Christina Alexopoulou; Antonios Valachis; Sofia Maraki; Dimitra Dimopoulou; Dimitrios Georgopoulos; George Samonis
Journal:  Clin Infect Dis       Date:  2010-10-25       Impact factor: 9.079

4.  Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study.

Authors:  I P Korbila; A Michalopoulos; P I Rafailidis; D Nikita; G Samonis; M E Falagas
Journal:  Clin Microbiol Infect       Date:  2009-09-02       Impact factor: 8.067

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.